Data Don’t Show Clear Link Between Weight-Loss Drugs and Suicidal Ideation: FDA

The FDA says Ozempic and Wegovy do not clearly show ties to suicidal ideation; more data is needed to investigate the drugs’ mental health risks.

Boxes of the diabetes drug Ozempic rest on a pharmacy counter in Los Angeles, California, on April 17, 2023. Mario Tama/Getty Images

There is no evidence weight-loss drugs like Wegovy and Ozempic are tied to suicidal ideation, the U.S. Food and Drug Administration said in its preliminary review released Thursday, Jan. 11.

“We determined that the information in these reports did not demonstrate a clear relationship with the use of GLP-1 RAs,” the FDA wrote.